Visit our new Alternative Investment section.Click here

Less Ads, More Data, More Tools Register for FREE

Venn Life Sciences Says Strong First Half Driven By Contract Wins

Thu, 13th Aug 2015 06:45

LONDON (Alliance News) - Venn Life Sciences PLC, a clinical research organisation, said Thursday it has shown continued growth so far in 2015 and increased company billings significantly.

Venn Life said it had a strong first half of 2015, with company billings greater than EUR4.0 million, more than double the EUR1.5 million it billed in the same period last year. The group said contract wins totalled more than EUR9.0 million in the half to the end of June.

"Our fee income figures highlight the steady and consistent growth of Venn Life year on year with both repeat business and organic growth contributing to our excellent results and ability to win projects internationally. Our market continues to grow steadily and with a healthy pipeline of prospects we are well positioned to deliver further growth," Venn Life Chief Executive Officer Tony Richardson said.

Venn Life will announce its interim results for the six months ended June 30 on the September 22 .

By Preten Patel; pretenpatel@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.


Shares in this article

Related News

Open Orphan Begins London Trading Following Venn Life Merger
28 Jun 2019

Open Orphan Begins London Trading Following Venn Life Merger

(Alliance News) - Shares in Open Orphan PLC began trading in London on Friday following the combination of Venn Life Sciences Holdings PLC and Open Or...

WINNERS & LOSERS SUMMARY: Ted Baker Sinks After Profit Warning
11 Jun 2019

WINNERS & LOSERS SUMMARY: Ted Baker Sinks After Profit Warning

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 2.5...

Anglo American + 8 more shares
Venn Life Sciences Raises GBP4.5 Million As Loss Widens In 2018 (ALLISS)
11 Jun 2019

Venn Life Sciences Raises GBP4.5 Million As Loss Widens In 2018 (ALLISS)

LONDON (Alliance News) - Venn Life Sciences Holdings PLC on Tuesday said it has conditionally raised GBP4.5 million before expenses through a share pl...